-
1Academic Journal
المؤلفون: K. -H. Ma, K. -H. Kim, A. Dixit, I. -M. Chung, J. -G. Gwag, T. -S. Kim, Y. -J. Park
المصدر: Biologia Plantarum, Vol 54, Iss 2, Pp 272-278 (2010)
مصطلحات موضوعية: heterozygosity, job's tears, polymorphism, simple sequence repeats, Biology (General), QH301-705.5, Plant ecology, QK900-989
وصف الملف: electronic resource
-
2Academic Journal
المؤلفون: Kathryn R. Bowles, Derian A. Pugh, Yiyuan Liu, Tulsi Patel, Alan E. Renton, Sara Bandres-Ciga, Ziv Gan-Or, Peter Heutink, Ari Siitonen, Sarah Bertelsen, Jonathan D. Cherry, Celeste M. Karch, Steven J. Frucht, Brian H. Kopell, Inga Peter, Y. J. Park, International Parkinson’s Disease Genomics Consortium (IPDGC), Alexander Charney, Towfique Raj, John F. Crary, A. M. Goate
المصدر: Molecular Neurodegeneration, Vol 17, Iss 1, Pp 1-21 (2022)
مصطلحات موضوعية: 17q21.31, Parkinson’s disease, LRRC37A, Copy number variation, Astrocytes, Neurology. Diseases of the nervous system, RC346-429, Geriatrics, RC952-954.6
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1750-1326
-
3Academic Journal
المؤلفون: M. S. Brose, Yu. Panaseykin, B. Konda, C. de la Fouchardiere, B. G.M. Hughes, A. G. Gianoukakis, Y. J. Park, I. Romanov, M. K. Krzyzanowska, S. Leboulleux, T. A. Binder, C. Dutcus, R. Xie, M. H. Taylor
المساهمون: M.S. Brose: Медицинская школа Пенсильванского университета получила грант на проведение этого исследования, автор получал гонорары за консультации от Eisai, Bayer, Lilly, Loxo и Blueprint Medicines. Yu. Panaseykin: конфликт интересов отсутствует. B. Konda: финансирование исследований (все финансирование для учреждения): Eisai, Merck, Bristol Myers Squibb, Xencor и Eli Lilly & Co. C. de la Fouchardiere: гонорары – Eisai, Roche, Servier, Amgen, Bayer, Pierre Fabre Oncologie и Bristol Myers Squibb, нефинансовая поддержка – Roche, Servier, Amgen, Bayer, Pierre Fabre Oncologie и Bristol Myers Squibb. B.G.M. Hughes: член консультационного совета в Eisai, MSD, Bristol Myers Squibb, Roche, AZ, Pfizer, Boehringer Ingelheim и Takeda. A.G. Gianoukakis: участник медицинского консультационного совета в Eisai и Blueprint. Y.J. Park: конфликт интересов отсутствует. I. Romanov: гонорары – Eisai, Bristol Myers Squibb и Merck Serono. M.K. Krzyzanowska: финансирование исследований (учреждение) – Eisai, Exelixis, Ipsen, гонорары за консультации – Eisai, Bayer, and Lilly. S. Leboulleux: финансирование исследований (учреждение) от Novartis и Sanofi Genzyme, член консультационного совета Eisai, Bayer и Lilly. T.A. Binder: бывший сотрудник (и нынешний консультант) Eisai Inc. C. Dutcus: сотрудник Eisai Inc. R. Xie: сотрудник Eisai Inc. M.H. Taylor: консультант/член консультационного совета (выплачивается вознаграждение) – Bristol Myers Squibb, Eisai Inc., Novartis, Bayer, Sanofi/ Genzyme, Array Biopharma, LOXO Oncology, Blueprint Medicines и Arqule, бюро спикеров (выплачивается гонорар): Bristol Myers Squibb и Eisai Inc., финансирование исследований (все финансирование для учреждения) – Bristol Myers Squibb, Merck Sharp & Dohme Corp, Pharmacyclics, AstraZeneca, Eisai, Incyte, EMD Serono, Novartis, Seattle Genetics, AbbVie, Genentech, Eli Lilly, Roche, Acerta Pharma, Genzyme Corporation и Pfizer.
المصدر: Head and Neck Tumors (HNT); Том 12, № 1 (2022); 86-98 ; Опухоли головы и шеи; Том 12, № 1 (2022); 86-98 ; 2411-4634 ; 2222-1468 ; 10.17650/2222-1468-2022-12-1
مصطلحات موضوعية: стартовая доза, радиойодрефрактерный дифференцированный рак щитовидной железы, ингибитор тирозинкиназ
وصف الملف: application/pdf
Relation: https://ogsh.abvpress.ru/jour/article/view/740/518; Bray F., Ferlay J., Soerjomataram I. et al. Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394–424.; Cabanillas M. E., Habra M. A. Lenvatinib: role in thyroid cancer and other solid tumors. Cancer Treat Rev 2016;42:47–55.; Eustatia-Rutten C. F., Corssmit E. P., Biermasz N. R. et al. Survival and death causes in differentiated thyroid carcinoma. J Clin Endocrinol Metab 2006;91(1):313–9.; Araque K. A., Gubbi S., Klubo-Gwiezdzinska J. Updates on the management of thyroid cancer. Horm Metab Res 2020;52 (8):562–77.; Fleeman N., Houten R., Chaplin M. et al. A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine. BMC Cancer 2019;19(1):1209.; Busaidy N. L., Cabanillas M. E. Differentiated thyroid cancer: management of patients with radioiodine nonresponsive disease. J Thyroid Res 2012;2012:618985.; Brose M. S., Nutting C. M., Jarzab B. et al. DECISION investigators. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, doubleblind, Phase 3 trial. Lancet 2014;384(9940):319–28.; Matsui J., Funahashi Y., Uenaka T. et al. Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase. Clin Cancer Res 2008;14(17):5459–65.; Matsui J., Yamamoto Y., Funahashi Y. et al. E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition. Int J Cancer 2008;122(3):664–71.; Tohyama O., Matsui J., Kodama K. et al. Antitumor activity of lenvatinib (e7080): an angiogenesis inhibitor that targets multiple receptor tyrosine kinases in preclinical human thyroid cancer models. J Thyroid Res 2014;2014:638747.; Yamamoto Y., Matsui J., Matsushima T. et al. Lenvatinib, an angiogenesis inhibitor targeting VEGFR / FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage. Vasc Cell 2014;6:18.; Schlumberger M., Tahara M., Wirth L. J. et al. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. N Engl J Med 2015;372(7):621–30.; Lenvima (lenvatinib) [prescribing information]. Eisai Inc;2020.; Locati L. D., Piovesan A., Durante C. et al. Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodinerefractory differentiated thyroid cancer patients in Italy. Eur J Cancer 2019;118:35–40.; Kim S. Y., Kim S. M., Chang H. et al. Safety of tyrosine kinase inhibitors in patients with differentiated thyroid cancer: real-world use of lenvatinib and sorafenib in Korea. Front Endocrinol 2019;10:384.; Hayato S., Shumaker R., Ferry J. et al. Exposure-response analysis and simulation of lenvatinib safety and efficacy in patients with radioiodine-refractory differentiated thyroid cancer. Cancer Chemother Pharmacol 2018;82(6):971–8.; Robinson B., Schlumberger M., Wirth L. J. et al. Characterization of tumor size changes over time from the Phase 3 study of lenvatinib in thyroid cancer. J Clin Endocrinol Metab 2016;101(11):4103–9.; NCCN Thyroid Carcinoma Panel. Thyroid carcinoma. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Version 1. 2021. Accessed June 2, 2021. Available at: https://www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf.; Filetti S., Durante C., Hartl D. et al. ESMO Guidelines Committee. Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2019;30(12):1856–83.; Hao Z., Wang P. Lenvatinib in management of solid tumors. Oncologist 2020;25(2):e302–10.; Kudo M., Finn R. S., Qin S. et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised Phase 3 non-inferiority trial. Lancet 2018;391(10126):1163–73.; Bullock J. M., Rahman A., Liu Q. Lessons learned: dose selection of small moleculetargeted oncology drugs. Clin Cancer Res 2016;22(11):2630–8.; https://ogsh.abvpress.ru/jour/article/view/740
-
4Academic Journal
المؤلفون: M. Choi, J. Kim, J. Lee, M. Kim, Y.-J. Park, B. Holben, T. F. Eck, Z. Li, C. H. Song
المصدر: Atmospheric Measurement Techniques, Vol 11, Pp 385-408 (2018)
مصطلحات موضوعية: Environmental engineering, TA170-171, Earthwork. Foundations, TA715-787
وصف الملف: electronic resource
-
5Academic Journal
المؤلفون: K. H. Park, S. J. Kim, M. J. Hwang, H. J. Song, Y. J. Park
المصدر: eXPRESS Polymer Letters, Vol 11, Iss 1, Pp 14-20 (2017)
مصطلحات موضوعية: Nanocomposites, Mineralization, Chitosan, Simulated body fluid, Calcium phosphate, Materials of engineering and construction. Mechanics of materials, TA401-492, Chemical technology, TP1-1185
وصف الملف: electronic resource
-
6Academic Journal
المؤلفون: M. Choi, J. Kim, J. Lee, M. Kim, Y.-J. Park, U. Jeong, W. Kim, H. Hong, B. Holben, T. F. Eck, C. H. Song, J.-H. Lim, C.-K. Song
المصدر: Atmospheric Measurement Techniques, Vol 9, Iss 3, Pp 1377-1398 (2016)
مصطلحات موضوعية: Environmental engineering, TA170-171, Earthwork. Foundations, TA715-787
وصف الملف: electronic resource
-
7
المصدر: Europace. 25
مصطلحات موضوعية: Physiology (medical), Cardiology and Cardiovascular Medicine
-
8
المؤلفون: A. Courbet, J. Hansen, Y. Hsia, N. Bethel, Y.-J. Park, C. Xu, A. Moyer, S. E. Boyken, G. Ueda, U. Nattermann, D. Nagarajan, D. Silva, W. Sheffler, J. Quispe, A. Nord, N. King, P. Bradley, D. Veesler, J. Kollman, D. Baker
المساهمون: University of Washington [Seattle], Howard Hughes Medical Institute [Boston] (HHMI), Howard Hughes Medical Institute (HHMI)-Harvard Medical School [Boston] (HMS), Hong Kong University of Science and Technology (HKUST), Centre de Biologie Structurale [Montpellier] (CBS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Fred Hutchinson Cancer Research Center [Seattle] (FHCRC), Nord, Ashley
المصدر: Science
Science, 2022, 376 (6591), pp.383-390. ⟨10.1126/science.abm1183⟩مصطلحات موضوعية: Motion, Multidisciplinary, Cryoelectron Microscopy, [SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology, Proteins, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology
وصف الملف: application/pdf
-
9Academic Journal
المؤلفون: M. Hidaka, K. Ohashi, R. P. Wijesundera, L. S. R. Kumara, M. Watanabe, K. Koga, Jae-Young Choi, N. E. Sung, Y. J. Park
المصدر: Cerâmica, Vol 57, Iss 341, Pp 106-114 (2011)
مصطلحات موضوعية: celadons Hizen, esmalte de celadon, microestrutura, HIZEN celadons, celadon glaze, microstructure, Engineering (General). Civil engineering (General), TA1-2040
وصف الملف: electronic resource
-
10
المؤلفون: Y. J. Park, B. Seipel, H. Holzmann
المصدر: ASME 2021 Conference on Smart Materials, Adaptive Structures and Intelligent Systems.
مصطلحات موضوعية: Computer science, business.industry, Electrical engineering, business, Energy harvesting, Wearable technology
-
11
-
12
المؤلفون: M. Weber, H. Holzmann, Y. J. Park, Heiko Atzrodt, Sara Perfetto, Athanasios Dafnis
المساهمون: Publica
المصدر: CEAS Aeronautical Journal 12(2), 331-344 (2021). doi:10.1007/s13272-021-00502-0
مصطلحات موضوعية: 010302 applied physics, Polypropylene, Materials science, Aerospace Engineering, Transportation, 02 engineering and technology, Bending, 021001 nanoscience & nanotechnology, 01 natural sciences, Piezoelectricity, Characterization (materials science), chemistry.chemical_compound, chemistry, Flexural strength, 0103 physical sciences, Power output, Composite material, ddc:620, 0210 nano-technology, Energy harvesting, Tensile testing
-
13
المؤلفون: Y-J. Park, Jayhoon Chung, Srikanth Krishnan, Pavan Kumar Vaitheeswaran, C-S. Lee, Ganesh Subbarayan
المصدر: IRPS
مصطلحات موضوعية: Stress (mechanics), Cyclic stress, Materials science, Reliability (semiconductor), Amplitude, chemistry, Duty cycle, chemistry.chemical_element, Dielectric, Composite material, Current (fluid), Copper
-
14
المؤلفون: Jae-Hwan Cho, Y. J. Park, M. S. Kim, Ho-Nyeon Lee, J. D. Rhim
المصدر: Radiation Effects and Defects in Solids. 173:643-656
مصطلحات موضوعية: Nuclear and High Energy Physics, Radiation, Materials science, Alloy, X-ray, chemistry.chemical_element, 02 engineering and technology, Test method, engineering.material, 021001 nanoscience & nanotechnology, Condensed Matter Physics, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, chemistry, Tungsten carbide, Electromagnetic shielding, engineering, General Materials Science, Tube (fluid conveyance), Composite material, 0210 nano-technology, Base metal, Cobalt
-
15
المؤلفون: J I Han, Sung-Geun Lee, Lae-Hyung Kang, H G Cho, Y J Park, A R Lee, S Y Paik, Yu-Jung Won
المصدر: Epidemiol Infect
مصطلحات موضوعية: Male, 0301 basic medicine, Epidemiology, Sequence analysis, 030106 microbiology, Genome, Viral, Genome, Parvoviridae Infections, 03 medical and health sciences, Human bocavirus, Republic of Korea, Genotype, Humans, Amino Acid Sequence, ORFS, Phylogeny, Whole genome sequencing, Genetics, Original Paper, Whole Genome Sequencing, Phylogenetic tree, biology, Parvovirus, Infant, biology.organism_classification, 030104 developmental biology, Infectious Diseases, Sequence Alignment
-
16Academic Journal
المؤلفون: P. Bambade, M. Alabau Pons, J. Amann, D. Angal-Kalinin, R. Apsimon, S. Araki, A. Aryshev, S. Bai, P. Bellomo, D. Bett, G. Blair, B. Bolzon, S. Boogert, G. Boorman, P. N. Burrows, G. Christian, P. Coe, B. Constance, J.-P. Delahaye, L. Deacon, E. Elsen, A. Faus-Golfe, M. Fukuda, J. Gao, N. Geffroy, E. Gianfelice-Wendt, H. Guler, H. Hayano, A.-Y. Heo, Y. Honda, J. Y. Huang, W. H. Hwang, Y. Iwashita, A. Jeremie, J. Jones, Y. Kamiya, P. Karataev, E.-S. Kim, H.-S. Kim, S. H. Kim, S. Komamiya, K. Kubo, T. Kume, S. Kuroda, B. Lam, A. Lyapin, M. Masuzawa, D. McCormick, S. Molloy, T. Naito, T. Nakamura, J. Nelson, D. Okamoto, T. Okugi, M. Oroku, Y. J. Park, B. Parker, E. Paterson, C. Perry, M. Pivi, T. Raubenheimer, Y. Renier, J. Resta-Lopez, C. Rimbault, M. Ross, T. Sanuki, A. Scarfe, D. Schulte, A. Seryi, C. Spencer, T. Suehara, R. Sugahara, C. Swinson, T. Takahashi, T. Tauchi, N. Terunuma, R. Tomas, J. Urakawa, D. Urner, M. Verderi, M.-H. Wang, M. Warden, M. Wendt, G. White, W. Wittmer, A. Wolski, M. Woodley, Y. Yamaguchi, T. Yamanaka, Y. Yan, H. Yoda, K. Yokoya, F. Zhou, F. Zimmermann
المصدر: Physical Review Special Topics. Accelerators and Beams, Vol 13, Iss 4, p 042801 (2010)
مصطلحات موضوعية: Nuclear and particle physics. Atomic energy. Radioactivity, QC770-798
Relation: http://doi.org/10.1103/PhysRevSTAB.13.042801; https://doaj.org/toc/1098-4402; https://doaj.org/article/69a62c9162de4b4c8cc0449fd7d33a28
-
17
المؤلفون: Jun Won Yun, H. G. Cho, Chul Jong Park, Junguee Lee, Sung-Geun Lee, S Y Paik, Y J Park
المصدر: Epidemiol Infect
مصطلحات موضوعية: 0301 basic medicine, Genotype, Epidemiology, Sequence analysis, viruses, Genome, Viral, Biology, medicine.disease_cause, Genome, Viral Proteins, 03 medical and health sciences, Republic of Korea, Prevalence, medicine, Amino Acid Sequence, Peptide sequence, Phylogeny, Caliciviridae Infections, Sequence (medicine), Genetics, Phylogenetic tree, Strain (biology), Norovirus, virus diseases, Original Papers, Gastroenteritis, 030104 developmental biology, Infectious Diseases, Sequence Alignment
-
18
المصدر: Cellular and molecular life sciences : CMLS. 78(7)
مصطلحات موضوعية: Ribosomal Proteins, DNA Adducts, Xeroderma Pigmentosum, DNA Repair, DNA Helicases, Humans, Transcription Factor TFIIH, DNA Damage, HeLa Cells, Xeroderma Pigmentosum Group D Protein
-
19
المؤلفون: Y J Park, M.H. Bae, Y. Cho, H.S. Park, J.H. Lee, Se Yong Jang, H N Kim, S C Chae, D.H. Yang, B E Park
المصدر: European Heart Journal. 40
مصطلحات موضوعية: medicine.medical_specialty, business.industry, medicine.medical_treatment, medicine, Percutaneous coronary intervention, cardiovascular diseases, Cardiology and Cardiovascular Medicine, Intensive care medicine, business, Outcome (game theory)
-
20Academic Journal
المؤلفون: C. K. Hyon, S. C. Choi, S. W. Hwang, B. D. Min, D. Ahn, Y. J. Park, E. K. Kim
المساهمون: The Pennsylvania State University CiteSeerX Archives
وصف الملف: application/pdf
Relation: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.565.623; http://nano.korea.ac.kr/paper/2001/Int_journal_2001_3.pdf